SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-016195
Filing Date
2018-11-14
Accepted
2018-11-14 17:16:18
Documents
75
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 490704
2 ex31-1.htm EX-31.1 12296
3 ex31-2.htm EX-31.2 11914
4 ex32-1.htm EX-32.1 7719
5 ex32-2.htm EX-32.2 7544
  Complete submission text file 0001493152-18-016195.txt   3539438

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xtnt-20180930.xml EX-101.INS 554816
7 XBRL SCHEMA FILE xtnt-20180930.xsd EX-101.SCH 46169
8 XBRL CALCULATION FILE xtnt-20180930_cal.xml EX-101.CAL 76723
9 XBRL DEFINITION FILE xtnt-20180930_def.xml EX-101.DEF 156140
10 XBRL LABEL FILE xtnt-20180930_lab.xml EX-101.LAB 338432
11 XBRL PRESENTATION FILE xtnt-20180930_pre.xml EX-101.PRE 268293
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 181185098
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1